Luyan Pharma Co.,Ltd. (SHE:002788)

Luyan Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 26, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,492	3,190	3,493	3,236	3,034	3,081
Market Cap Growth	97.05%	-8.68%	7.92%	6.66%	-1.51%	15.67%
Enterprise Value	11,061	7,860	8,216	7,721	7,052	6,338
Last Close Price	16.71	7.88	8.31	7.45	6.74	6.68
PE Ratio	20.89	9.23	9.61	9.38	9.92	11.56
PS Ratio	0.31	0.16	0.18	0.17	0.17	0.20
PB Ratio	1.99	1.00	1.17	1.16	1.19	1.26
P/TBV Ratio	2.50	1.27	1.52	1.44	1.49	1.55
P/FCF Ratio	19.23	14.74	4.48	-	-	-
P/OCF Ratio	10.65	5.52	2.67	13.94	-	51.01
EV/Sales Ratio	0.53	0.38	0.41	0.40	0.40	0.41
EV/EBITDA Ratio	14.65	10.47	10.90	10.19	10.77	10.59
EV/EBIT Ratio	17.84	11.49	11.82	10.99	11.75	11.52
EV/FCF Ratio	32.76	36.33	10.54	-	-	-
Debt / Equity Ratio	1.53	1.55	1.63	1.82	1.75	1.43
Debt / EBITDA Ratio	6.63	6.09	5.96	6.23	6.29	5.85
Debt / FCF Ratio	14.82	22.88	6.23	-	-	-
Asset Turnover	1.64	1.68	1.68	1.79	1.89	1.93
Inventory Turnover	7.09	6.97	7.16	7.44	7.52	7.56
Quick Ratio	0.77	0.77	0.79	0.79	0.80	0.81
Current Ratio	1.10	1.15	1.16	1.17	1.19	1.22
Return on Equity (ROE)	9.69%	11.27%	12.64%	13.12%	12.17%	12.31%
Return on Assets (ROA)	3.05%	3.50%	3.68%	4.03%	4.04%	4.27%
Return on Invested Capital (ROIC)	6.06%	7.10%	7.44%	7.61%	7.35%	7.80%
Return on Capital Employed (ROCE)	16.40%	17.00%	18.40%	20.20%	20.20%	20.70%
Earnings Yield	4.74%	10.84%	10.41%	10.66%	10.08%	8.65%
FCF Yield	5.20%	6.78%	22.33%	-2.95%	-20.29%	-3.58%
Dividend Yield	2.08%	4.44%	3.61%	4.03%	4.45%	2.99%
Payout Ratio	106.59%	93.69%	93.56%	95.92%	81.76%	79.93%
Buyback Yield / Dilution	0.25%	-0.42%	0.28%	-0.17%	-7.46%	-9.83%
Total Shareholder Return	2.24%	4.02%	3.89%	3.86%	-3.00%	-6.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.